BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2863106)

  • 1. Inhibition of microsomal phenytoin metabolism by nafimidone and related imidazoles. Potency and structural considerations.
    Kapetanovic IM; Kupferberg HJ
    Drug Metab Dispos; 1985; 13(4):430-7. PubMed ID: 2863106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nafimidone, an imidazole anticonvulsant, and its metabolite as potent inhibitors of microsomal metabolism of phenytoin and carbamazepine.
    Kapetanovic IM; Kupferberg HJ
    Drug Metab Dispos; 1984; 12(5):560-4. PubMed ID: 6149905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition and induction of hepatic drug metabolism in rats and mice by nafimidone and its major metabolite nafimidone alcohol.
    Rush WR; Smith SA; Mulvey JH; Graham DJ; Chaplin MD
    Drug Metab Dispos; 1987; 15(4):571-8. PubMed ID: 2888633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the anticonvulsants, denzimol and nafimidone, with liver cytochrome P450 in the rat.
    Salmona M; Conti I; Testa R; Fracasso C; Caccia S
    J Pharm Pharmacol; 1988 Jan; 40(1):17-21. PubMed ID: 2896768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of microsomal enzyme activity of the liver by various H2 receptor antagonists].
    Jensen JC; Gugler R
    Z Gastroenterol; 1987 Feb; 25(2):112-8. PubMed ID: 2882636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of (arylalkyl)imidazole anticonvulsants: comparison of the (fluorenylalkyl)imidazoles with nafimidone and denzimol.
    Robertson DW; Krushinski JH; Beedle EE; Leander JD; Wong DT; Rathbun RC
    J Med Chem; 1986 Sep; 29(9):1577-86. PubMed ID: 3746810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of imidazole- and 2-methyl imidazole-containing farnesyl-protein transferase inhibitors: interaction with and metabolism by rat hepatic cytochrome P450s.
    Tang C; Chiba M; Nishime J; Hochman JH; Chen I; Williams TM; Lin JH
    Drug Metab Dispos; 2000 Jun; 28(6):680-6. PubMed ID: 10820141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of nafimidone in rats.
    Graham DJ; Hama KM; Smith SA; Kurz L; Chaplin MD; Hall DJ
    Drug Metab Dispos; 1987; 15(4):565-70. PubMed ID: 2888632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of N- and C-hydroxylations of 2-acetylaminofluorene in male Sprague-Dawley rat liver microsomes: implications for carcinogenesis.
    McManus ME; Minchin RF; Sanderson N; Wirth PJ; Thorgeirsson SS
    Cancer Res; 1983 Aug; 43(8):3720-4. PubMed ID: 6861141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolism of nafimidone hydrochloride in the dog, primates and man.
    Rush WR; Alexander OF; Hall DJ; Dow RJ; Tokes L; Kurz L; Graham DJ
    Xenobiotica; 1990 Jan; 20(1):123-32. PubMed ID: 2109431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of insecticide synergists on microsomal oxidation of estradiol and ethynylestradiol and on microsomal drug metabolism.
    Bolt HM; Kassel H
    Xenobiotica; 1976 Jan; 6(1):33-8. PubMed ID: 1274368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heme-coordinating analogs of lauric acid as inhibitors of fatty acid omega-hydroxylation.
    Lu P; Alterman MA; Chaurasia CS; Bambal RB; Hanzlik RP
    Arch Biochem Biophys; 1997 Jan; 337(1):1-7. PubMed ID: 8990261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of classic and atypical neuroleptics on caffeine oxidation in rat liver microsomes.
    Daniel WA; Kot M; Wójcikowski J
    Pol J Pharmacol; 2003; 55(6):1055-61. PubMed ID: 14730101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction and inhibition of rat hepatic drug metabolism by N-substituted imidazole drugs.
    Ritter JK; Franklin MR
    Drug Metab Dispos; 1987; 15(3):335-43. PubMed ID: 2886308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreases in phenytoin hydroxylation activities catalyzed by liver microsomal cytochrome P450 enzymes in phenytoin-treated rats.
    Yamazaki H; Komatsu T; Takemoto K; Saeki M; Minami Y; Kawaguchi Y; Shimada N; Nakajima M; Yokoi T
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):427-34. PubMed ID: 11259327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of benzo(a)pyrene metabolism in hepatic microsomes from untreated and induced rats by imidazole derivatives which inhibit monooxygenase activity and enhance epoxide hydrolase activity.
    James MO; Little PJ
    Drug Metab Dispos; 1983; 11(4):350-4. PubMed ID: 6137342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 1'-hydroxylation of Rac-bufuralol by rat brain microsomes.
    Coleman T; Spellman EF; Rostami-Hodjegan A; Lennard MS; Tucker GT
    Drug Metab Dispos; 2000 Sep; 28(9):1094-9. PubMed ID: 10950855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The deleterious effect of Bordetella pertussis vaccine and poly(rI.rC) on the metabolism and disposition of phenytoin.
    Renton KW
    J Pharmacol Exp Ther; 1979 Feb; 208(2):267-70. PubMed ID: 762660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ethanol and imidazole pretreatments on hepatic monooxygenase activities in the rat.
    Reinke LA; Sexter SH; Rikans LE
    Res Commun Chem Pathol Pharmacol; 1985 Jan; 47(1):97-106. PubMed ID: 3983472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.